(Q40941958)

25 September 2017

1 reference

title

New concepts in the immunology of sickle cell disease (English)

1 reference

25 September 2017

0 references

Moore CM

1

1 reference

25 September 2017

Ehlayel M

series ordinal

2

1 reference

25 September 2017

Leiva LE

series ordinal

3

1 reference

25 September 2017

Sorensen RU

series ordinal

4

1 reference

25 September 2017

1 May 1996

1 reference

Annals of Allergy, Asthma & Immunology

25 September 2017

1 reference

25 September 2017

76

1 reference

25 September 2017

385-400; quiz 400-3

1 reference

25 September 2017

5

1 reference

Functional asplenia in sickle-cell anemia

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

An abnormality of the alternate pathway of complement activation in sickle-cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Decreased opsonization for Streptococcus pneumoniae in sickle cell disease: Studies on selected complement components and immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Increased activation of the alternative complement pathway in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Adhesion molecules in lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

1 reference

7 January 2021

Leukocyte migration and adhesion.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

1 reference

7 January 2021

Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

The immunoglobulin superfamily--domains for cell surface recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Integrins: versatility, modulation, and signaling in cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Primary structure of the leukocyte function-associated molecule-1 alpha subunit: an integrin with an embedded domain defining a protein superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Mutation of putative divalent cation sites in the alpha 4 subunit of the integrin VLA-4: distinct effects on adhesion to CS1/fibronectin, VCAM-1, and invasin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Activation of LFA-1 through a Ca2(+)-dependent epitope stimulates lymphocyte adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Divalent cation regulation of the function of the leukocyte integrin LFA-1

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

VLA proteins in the integrin family: structures, functions, and their role on leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

The vitronectin receptor serves as an accessory molecule for the activation of a subset of gamma/delta T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Fibrinogen, fibrinogen receptors, and the peptides that inhibit these interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Isolation of the thrombospondin membrane receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Identification of hyaluronic acid binding sites in the extracellular domain of CD44

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Physiology of Thrombospondin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Granulocyte proteases do not process endothelial cell-derived unusually large von Willebrand factor multimers to plasma vWF in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

alpha 1-Antitrypsin therapy in a case of thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Adhesive properties of haemopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Novel cell surface adhesion receptors involved in interactions between stromal macrophages and haematopoietic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Coexpression of two fibronectin receptors, VLA-4 and VLA-5, by immature human erythroblastic precursor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Cell surface antigen expression in human erythroid progenitors: erythroid and megakaryocytic markers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Unusually large von Willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Red blood cells from patients with sickle cell disease exhibit an increased adherence to cultured endothelium pretreated with tumour necrosis factor (TNF)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Platelet-activating factor secreted by DDAVP-treated monocytes mediates von Willebrand factor release from endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Enhanced release of von Willebrand factor by human endothelial cells in culture in the presence of phorbol myristate acetate and interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Study of platelet function in patients with sickle cell anemia during steady state and vaso-occlusive crisis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Is there an acute-phase response in steady-state sickle cell disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Acute phase reactants and severity of homozygous sickle cell disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Subclinical ischaemic episodes during the steady state of sickle cell anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Plasma and urinary leukotrienes in sickle cell disease: possible role in the inflammatory process

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Levels of tumor necrosis factor alpha/cachectin (TNF alpha) in sera from patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Acute-phase response and sickle crisis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Circulating adhesion molecules in disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Hypoxic induction of interleukin-8 gene expression in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Oxygen tension regulates neutrophil adhesion to human endothelial cells via an LFA-1-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Increased expression of ICAM-1 during reoxygenation in brain endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Increased circulating endothelial cells in sickle cell crisis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Coagulation Changes during the Steady State in Homozygous Sickle-Cell Disease in Jamaica

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

TNF in vascular pathology: the importance of platelet-endothelium interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Large-vessel occlusion in sickle cell disease: pathogenesis, clinical consequences, and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Cerebrovascular disease in sickle cell anemia: a clinical, pathological and radiological correlation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

The use of transcranial ultrasonography to predict stroke in sickle cell disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Sickle cell anemia; a composite study and survey

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Observation on the genesis of crises in sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

A study of the role of acute infections in precipitating crises in chronic hemolytic states

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Sickle-cell anaemia in the Accra district of the Gold Coast; a review of twenty cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

CHEMOPROPHYLAXIS OF HOMOZYGOUS SICKLERS WITH ANTIMALARIALS AND LONG-ACTING PENICILLIN.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Acute splenic sequestration and hypersplenism in the first five years in homozygous sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Acute splenic sequestration in homozygous sickle cell disease: natural history and management.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

In vitro antibody synthesis by peripheral blood mononuclear cells from patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Lymphocyte phenotype and function in chronically transfused children with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Serum immunoglobulin levels in patients having sickle cell syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Fat embolism syndrome associated with asthma and sickle cell-beta(+)-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Adhesion molecules and inflammatory injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Treatment of sickle cell anemia with hydroxyurea and erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

Extended inhibition of platelet aggregation with the orally active platelet inhibitor SC-54684A

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

SC-54684A: an orally active inhibitor of platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

New antithrombotic strategies for resistant thrombotic processes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963453-9

7 January 2021

10.1016/S1081-1206(10)63453-9

Identifiers

DOI

1 reference

25 September 2017

1 reference